Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11619 | 967 | 28.3 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
79 | 2 | DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE | 27337 |
11619 | 1 | IMPLANTABLE INSULIN PUMP//CONTINUOUS INTRAPERITONEAL INSULIN INFUSION//INTRAPERITONEAL INSULIN | 967 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IMPLANTABLE INSULIN PUMP | authKW | 355752 | 1% | 87% | 13 |
2 | CONTINUOUS INTRAPERITONEAL INSULIN INFUSION | authKW | 252607 | 1% | 100% | 8 |
3 | INTRAPERITONEAL INSULIN | authKW | 212252 | 1% | 61% | 11 |
4 | INTRAPERITONEAL INSULIN DELIVERY | authKW | 193401 | 1% | 88% | 7 |
5 | BRITTLE DIABETES | authKW | 106557 | 1% | 38% | 9 |
6 | DAWN PHENOMENON | authKW | 102294 | 1% | 36% | 9 |
7 | SUBCUTANEOUS INSULIN | authKW | 71758 | 1% | 45% | 5 |
8 | DIABETES CARE | journal | 67575 | 16% | 1% | 156 |
9 | CIPII | authKW | 63152 | 0% | 100% | 2 |
10 | IMPLANTED INSULIN PUMP | authKW | 63152 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 17700 | 52% | 0% | 501 |
2 | Medicine, General & Internal | 1999 | 22% | 0% | 212 |
3 | Engineering, Biomedical | 575 | 7% | 0% | 64 |
4 | Transplantation | 178 | 3% | 0% | 31 |
5 | Pediatrics | 58 | 4% | 0% | 36 |
6 | Medical Informatics | 29 | 1% | 0% | 8 |
7 | Primary Health Care | 27 | 1% | 0% | 6 |
8 | BIOLOGY, MISCELLANEOUS | 19 | 0% | 0% | 1 |
9 | MEDICINE, MISCELLANEOUS | 18 | 0% | 0% | 1 |
10 | Psychology, Psychoanalysis | 5 | 0% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED DIABET PROGRAM | 63152 | 0% | 100% | 2 |
2 | BOX 386 | 31576 | 0% | 100% | 1 |
3 | CARDIOVASC DIS METAB DISORDERS | 31576 | 0% | 100% | 1 |
4 | CENT PHARM COORDINATING | 31576 | 0% | 100% | 1 |
5 | CHIM DIABET SECT | 31576 | 0% | 100% | 1 |
6 | CHU NANCYINSERM INVEST CLIN | 31576 | 0% | 100% | 1 |
7 | DIABET METAB DISORDERS NUTR | 31576 | 0% | 100% | 1 |
8 | DIABET MOLEC DIS | 31576 | 0% | 100% | 1 |
9 | DIABETOL INSERM U341 | 31576 | 0% | 100% | 1 |
10 | DIATHECEA 7294 | 31576 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETES CARE | 67575 | 16% | 1% | 156 |
2 | DIABETES & METABOLISM | 32361 | 6% | 2% | 54 |
3 | DIABETOLOGIA | 12762 | 6% | 1% | 58 |
4 | ACTA DIABETOLOGICA LATINA | 12158 | 1% | 3% | 13 |
5 | TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS | 6940 | 1% | 2% | 12 |
6 | DIABETES RESEARCH CLINICAL AND EXPERIMENTAL | 6646 | 1% | 2% | 11 |
7 | DIABETES | 5279 | 5% | 0% | 45 |
8 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY | 4099 | 1% | 1% | 12 |
9 | MEDICAL PROGRESS THROUGH TECHNOLOGY | 3667 | 1% | 2% | 6 |
10 | LIFE SUPPORT SYSTEMS | 3261 | 0% | 3% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHAEPELYNCK, P , RIVELINE, JP , RENARD, E , HANAIRE, H , GUERCI, B , BAILLOT-RUDONI, S , SOLA-GAZAGNES, A , CATARGI, B , FONTAINE, P , MILLOT, L , ET AL (2014) ASSESSMENT OF A NEW INSULIN PREPARATION FOR IMPLANTED PUMPS USED IN THE TREATMENT OF TYPE 1 DIABETES.DIABETES TECHNOLOGY & THERAPEUTICS. VOL. 16. ISSUE 9. P. 582 -589 | 24 | 100% | 0 |
2 | RENARD, E , SCHAEPELYNCK-BELICAR, P , (2007) IMPLANTABLE INSULIN PUMPS. A POSITION STATEMENT ABOUT THEIR CLINICAL USE.DIABETES & METABOLISM. VOL. 33. ISSUE 2. P. 158-166 | 32 | 73% | 34 |
3 | SPAAN, N , TEPLOVA, A , STAM, G , SPAAN, J , LUCAS, C , (2014) SYSTEMATIC REVIEW: CONTINUOUS INTRAPERITONEAL INSULIN INFUSION WITH IMPLANTABLE INSULIN PUMPS FOR DIABETES MELLITUS.ACTA DIABETOLOGICA. VOL. 51. ISSUE 3. P. 339-351 | 26 | 76% | 4 |
4 | RENARD, E , (2004) IMPLANTABLE INSULIN DELIVERY PUMPS.MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES. VOL. 13. ISSUE 5-6. P. 328-335 | 31 | 79% | 4 |
5 | VAN DIJK, PR , LOGTENBERG, SJJ , GROENIER, KH , GANS, ROB , KLEEFSTRA, N , BILO, HJG , (2014) CONTINUOUS INTRAPERITONEAL INSULIN INFUSION IN TYPE 1 DIABETES: A 6-YEAR POST-TRIAL FOLLOW-UP.BMC ENDOCRINE DISORDERS. VOL. 14. ISSUE . P. - | 19 | 86% | 3 |
6 | THOMPSON, JS , DUCKWORTH, WC , (2001) INSULIN PUMPS AND GLUCOSE REGULATION.WORLD JOURNAL OF SURGERY. VOL. 25. ISSUE 4. P. 523 -526 | 24 | 96% | 2 |
7 | PINGET, M , JEANDIDIER, N , (1998) LONG TERM SAFETY AND EFFICACY OF INTRAPERITONEAL INSULIN INFUSION BY MEANS OF IMPLANTABLE PUMPS.HORMONE AND METABOLIC RESEARCH. VOL. 30. ISSUE 8. P. 475 -486 | 35 | 67% | 10 |
8 | VANCAUTER, E , POLONSKY, KS , SCHEEN, AJ , (1997) ROLES OF CIRCADIAN RHYTHMICITY AND SLEEP IN HUMAN GLUCOSE REGULATION.ENDOCRINE REVIEWS. VOL. 18. ISSUE 5. P. 716 -738 | 48 | 38% | 201 |
9 | SCHAEPELYNCK, P , DARMON, P , MOLINES, L , JANNOT-LAMOTTE, MF , TREGLIA, C , RACCAH, D , (2011) ADVANCES IN PUMP TECHNOLOGY: INSULIN PATCH PUMPS, COMBINED PUMPS AND GLUCOSE SENSORS, AND IMPLANTED PUMPS.DIABETES & METABOLISM. VOL. 37. ISSUE . P. S85-S93 | 26 | 58% | 14 |
10 | VAN DIJK, PR , LOGTENBERG, SJJ , GANS, ROB , BILO, HJG , KLEEFSTRA, N , (2014) INTRAPERITONEAL INSULIN INFUSION: TREATMENT OPTION FOR TYPE 1 DIABETES RESULTING IN BENEFICIAL ENDOCRINE EFFECTS BEYOND GLYCAEMIA.CLINICAL ENDOCRINOLOGY. VOL. 81. ISSUE 4. P. 488 -497 | 31 | 46% | 2 |
Classes with closest relation at Level 1 |